There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cassava Sciences (SAVA – Research Report), Meiragtx Holdings (MGTX – Research Report) and Aquestive Therapeutics (AQST – Research Report) with bullish sentiments. Cassava Sciences (SAVA) In a report released today, Soumit Roy from JonesTrading reiterated a Buy rating on Cassava Sciences, with a price target of $100.00. The company's shares closed last Wednesday at $18.78, close to its 52-week low of $13.84. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cassava-sciences-sava-meiragtx-holdings-mgtx-and-aquestive-therapeutics-aqst?utm_source=advfn.com&utm_medium=referral
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Oct 2022 to Nov 2022 Click Here for more Cassava Sciences Charts.
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Nov 2021 to Nov 2022 Click Here for more Cassava Sciences Charts.